PAG-led Sekhmet Pharmaventures announces the hiring of Anil Khubchandani as MD and CEO

A private equity consortium led by PAG has hired Anil Khubchandani as managing director and CEO of Sekhmet Pharmaventures Private Ltd, an investment platform established to nurture and grow India's next generation of active pharmaceutical ingredient (API) companies.

Khubchandani, in his most recent role, has served as Co-CEO and Whole-time Director of Jubilant Ingrevia. Over his 20-year career at Jubilant Ingrevia, Khubchandani was a strategic business leader, developed high-performing teams, and oversaw solutions and offerings for pharmaceutical, agrochemical, and industrial clients.

Sekhmet Pharmaventures is the India arm of Gamot API Pte. Ltd., a Singapore-based platform launched by PAG along with Indian private equity firms CX Partners and Samara Capital to buy stakes in fast-growing pharma companies. The platform acquired control of Chennai-based Anjan Drug Pvt. Ltd. in October 2020 and the Hyderabad-based Optimus Drugs group of companies in September 2022. Gamot API is majority owned by PAG, which has invested over $1.5 billion in India across its private equity and debt businesses.